Loading
Distinct shells carrying a filed role for this person — not every shell they have ever touched.
Of those vehicles, the ones that closed a merger.
Announced but not closed, and still hunting.
No closed vehicle here has both a stored price and a filed trust value to score it against.
1 vehicle on file, newest listing first
Jessica Jensen ​ ​ ​ ​ 41 ​ ​ ​ Executive Vice President Clinical Development ​ Dr. Rajesh K. Malik, M.D. (3) ​ ​ ​ ​ 62 ​ ​ ​ Class I Director ​ Jonathan Ross Goodman (1) ​ ​ ​ ​ 53 ​ ​ ​ Class I Director ​ Margaret E. Gilmour (1) ​ ​ ​ ​ 61 ​ ​ ​ Class I Director ​ Gerald Hogue (1) ​ ​ ​ ​ 63 ​ ​ ​ Class III Director ​ David C. Lubner (2) ​ ​ ​ ​ 56 ​ ​ ​ Class II Director ​ Dr. Yael Margolin, Ph.D. (1) ​ ​ ​ ​ 68 ​ ​ ​ Class II Director ​ Executive Officers Dr. Joe McCann, Ph.D. has served as Chief Executive Officer of Old POINT since January 2020 and of New POINT since June 2021 and as a member of the board of directors of Old POINT since September 2019 and of New POINT since June 2021. Dr.
This record is keyed to SEC CIK 0001868742 — the identifier this person files under in their own name. Every vehicle above is a filing made under that CIK, so “the same person on two shells” is a fact about an SEC identifier rather than about a name that happens to match.
Roles are the strings the filings used, in the order they were filed. Nothing on this page ranks them, infers seniority, or offers a reason why any two of these names recur — a recurrence is a count, and the filings that produced it are linked beside every row. We also hold 150 institutional-holder rows on these vehicles, under 46 distinct name strings, and none of them is counted across vehicles: that table has no CIK column, and matching holders by name would merge firms that are not the same firm.